These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38656587)

  • 21. A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography.
    Roh HS; Song HM; Yun BR; Kang HK; Choi KS; Park YJ; Kim DS; Kim SH; Mo IP; An BS; Ahn CY
    Mol Med Rep; 2015 Apr; 11(4):2819-24. PubMed ID: 25482872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y; Han L; Palladino G; Ferrari A; Xie Y; Carfi A; Dormitzer PR; Settembre EC
    Vaccine; 2015 Oct; 33(41):5342-5349. PubMed ID: 26348403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel synthetic receptor-based immunoassay for influenza vaccine quantification.
    Hashem AM; Gravel C; Farnsworth A; Zou W; Lemieux M; Xu K; Li C; Wang J; Goneau MF; Merziotis M; He R; Gilbert M; Li X
    PLoS One; 2013; 8(2):e55428. PubMed ID: 23424631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a universal influenza vaccine: different approaches for one goal.
    Sautto GA; Kirchenbaum GA; Ross TM
    Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
    Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of pandemic influenza A (H1N1) virus hemagglutinin specific polyclonal antibodies for biosensor applications.
    Athmaram TN; Saraswat S; Sikarwar B; Verma SK; Singh AK; Boopathi M
    J Med Virol; 2014 Mar; 86(3):363-71. PubMed ID: 24114800
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza virus hemagglutinin stalk-based antibodies and vaccines.
    Krammer F; Palese P
    Curr Opin Virol; 2013 Oct; 3(5):521-30. PubMed ID: 23978327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
    Chae W; Kim P; Kim H; Cheong YC; Kim YS; Kang SM; Seong BL
    Sci Rep; 2019 Dec; 9(1):19675. PubMed ID: 31873147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC
    Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    Reneer ZB; Jamieson PJ; Skarlupka AL; Huang Y; Ross TM
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.
    Zhang Y; Xu C; Zhang H; Liu GD; Xue C; Cao Y
    Viruses; 2019 Apr; 11(5):. PubMed ID: 31052339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y; Palladino G; Xie Y; Ferrari A; Ma X; Han L; Dormitzer PR; Settembre EC
    Vaccine; 2016 Jun; 34(29):3388-95. PubMed ID: 27154389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans.
    Miller MS; Tsibane T; Krammer F; Hai R; Rahmat S; Basler CF; Palese P
    J Infect Dis; 2013 Jan; 207(1):98-105. PubMed ID: 23087428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
    Vasudevan A; Woerner A; Schmeisser F; Verma S; Williams O; Weir JP
    Influenza Other Respir Viruses; 2018 Mar; 12(2):250-258. PubMed ID: 29152878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.
    Wyrzucki A; Dreyfus C; Kohler I; Steck M; Wilson IA; Hangartner L
    J Virol; 2014 Jun; 88(12):7083-92. PubMed ID: 24719426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
    PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A plant-based system for rapid production of influenza vaccine antigens.
    Shoji Y; Farrance CE; Bautista J; Bi H; Musiychuk K; Horsey A; Park H; Jaje J; Green BJ; Shamloul M; Sharma S; Chichester JA; Mett V; Yusibov V
    Influenza Other Respir Viruses; 2012 May; 6(3):204-10. PubMed ID: 21974811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and optimization of a multiplex anti-influenza peptide immunoassay.
    Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
    J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.